BiomX (PHGE) News Today $0.75 +0.11 (+16.67%) (As of 12/27/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesOwnershipSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing StandardsDecember 16, 2024 | markets.businessinsider.comBiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net Income Amid Rising ExpensesNovember 16, 2024 | finance.yahoo.comBiomX Inc: Promising Clinical Advancements and Strong Financial Position Justify Buy RatingNovember 15, 2024 | markets.businessinsider.comBiomX Inc. Reports Q3 2024 Financial TurnaroundNovember 15, 2024 | markets.businessinsider.comBiomX announces mandatory unit separationOctober 16, 2024 | finance.yahoo.comBiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround and Promising ...October 9, 2024 | finance.yahoo.comBiomX (AMEX:PHGE) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comBiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024September 3, 2024 | finance.yahoo.comBiomX Inc. (NYSEAMERICAN:PHGE) Short Interest UpdateBiomX Inc. (NYSEAMERICAN:PHGE - Get Free Report) saw a significant decline in short interest in August. As of August 15th, there was short interest totalling 58,100 shares, a decline of 92.9% from the July 31st total of 812,700 shares. Based on an average daily trading volume, of 30,100 shares, the short-interest ratio is currently 1.9 days.August 27, 2024 | marketbeat.comUpcoming Stock Splits This Week (August 26 to August 30) – Stay InvestedAugust 26, 2024 | msn.comEarnings call: BiomX reports Q2 2024 financials, clinical updatesAugust 18, 2024 | uk.investing.comBuy Rating for BiomX: Solid Financials and Promising Clinical Pipeline Signal Strong Future PerformanceAugust 16, 2024 | markets.businessinsider.comBiomX Buy Rating Affirmed by Analyst Michael Higgins on Strong Clinical Progress and Strategic AcquisitionsAugust 16, 2024 | markets.businessinsider.comBiomX receives NYSE American compliance extensionJuly 31, 2024 | investing.comLaidlaw & Co. Initiates Coverage of BiomX (PHGE) with Buy RecommendationMay 29, 2024 | msn.comBiomX Buy Rating Affirmed on Clinical Progress and Strategic AcquisitionMay 22, 2024 | markets.businessinsider.comBiomX Inc. (AMEX:PHGE) Q1 2024 Earnings Call TranscriptMay 22, 2024 | msn.comBiomX’s Strategic Progress and Positive Trials Fuel Buy RatingMay 21, 2024 | markets.businessinsider.comBiomX Inc. (PHGE) Q4 2023 Earnings Call TranscriptApril 5, 2024 | seekingalpha.comBiomX Inc. (AMEX:PHGE) Q4 2023 Earnings Call TranscriptApril 4, 2024 | msn.comBiomX’s Robust Financial Health and Promising Clinical Advancements Bolster Buy RatingApril 4, 2024 | markets.businessinsider.comAzitra stock slides on pricing stock offering to raise $5 millionFebruary 14, 2024 | msn.comBiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023November 30, 2023 | finance.yahoo.comWhy Is Bacterial Infection-Focused BiomX Stock Trading Lower Today?November 29, 2023 | benzinga.comBiomX mulls pivotal trial for antibacterial after Phase 1/2 data in cystic fibrosisNovember 29, 2023 | msn.comBiomX Announces Positive Results From Phase 1b/2a Study Of BX004 In Chronic Pulmonary InfectionsNovember 29, 2023 | markets.businessinsider.comBiomX: BX004 Phage Cocktail Part 2, Phase 1b/2a Clinical Results In Cystic Fibrosis Expected Any DayNovember 23, 2023 | seekingalpha.comPromising Clinical Trials and Financial Stability Bolster BiomX’s Buy Rating: An Analysis by Michael HigginsNovember 16, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: BiomX (PHGE), Quoin Pharmaceuticals (QNRX) and Precigen (PGEN)November 15, 2023 | markets.businessinsider.comBiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the 37th Annual North American Cystic Fibrosis ConferenceOctober 27, 2023 | finance.yahoo.comBiomX Announces the Appointment of Edward L. Williams to its Board of DirectorsOctober 18, 2023 | finance.yahoo.comBiomX Announces Completion of Patient Dosing in Part 2 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic FibrosisOctober 4, 2023 | finance.yahoo.comBiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the European Respiratory Society (ERS) International Congress 2023September 7, 2023 | finance.yahoo.comBiomX to Present at H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 6, 2023 | finance.yahoo.comBiomX Reports Second Quarter 2023 Financial Results and Provides Business UpdateAugust 9, 2023 | finance.yahoo.comBiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023August 3, 2023 | finance.yahoo.comNYSE American Initiates Delisting Proceedings for BiomX WarrantsJune 8, 2023 | finance.yahoo.comBiomX Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 15, 2023 | finance.yahoo.comBiomX Announces the Appointments of Jason M. Marks and Michael E. Dambach to Board of DirectorsMay 12, 2023 | finance.yahoo.comBiomX Announces Second Closing of $7.5 Million Private PlacementMay 5, 2023 | finance.yahoo.comBiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023March 27, 2023 | finance.yahoo.comWhy Is BiomX (PHGE) Stock Down 18% Today?February 24, 2023 | msn.comBrandon Toranzo Stands Atop Essex CountyJanuary 28, 2023 | msn.comPhage Therapy Market 2023 Expected to Reach Significant Rate by 2028January 17, 2023 | marketwatch.comBacteriophage Market 2023 : Industry Scenario, Strategies, Growth Factors and Forecast to 2028January 12, 2023 | marketwatch.comMd. biotech Adaptive Phage Therapeutics advances fight to wipe out superbugs in cystic fibrosisJanuary 12, 2023 | bizjournals.comWhy Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day SessionDecember 19, 2022 | msn.comFull Spectrum hosts gala to raise money for LGBTQ centerDecember 18, 2022 | msn.comBiomX To Present at H.C. Wainwright 1st Annual Investor Conference on BacteriophageNovember 29, 2022 | finance.yahoo.comBiomX, Inc. (PHGE) Q3 2022 Earnings Call TranscriptNovember 12, 2022 | seekingalpha.com Get BiomX News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Buy this Stock before Trump Takes Office! (Ad)To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowering the price of Behind the Markets to just $19 for the whole year! And with a full 30-day money back guarantee, you have nothing to lose. Get all the info here>>> PHGE Media Mentions By Week PHGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHGE News Sentiment▼1.000.55▲Average Medical News Sentiment PHGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHGE Articles This Week▼10▲PHGE Articles Average Week Get BiomX News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SRZN News Today HSTC News Today CLNN News Today QTTB News Today VNRX News Today SCYX News Today ATNM News Today LEXX News Today ALRN News Today VYNE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:PHGE) was last updated on 12/28/2024 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredIs Jeff Bezos Crowning the Next Nvidia?It doesn't matter what you think about AI... Because Jeff Bezos's massive load-up on one tiny tech company ...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWhile Buffett Buys Oil, This ETF Pays 22% YieldsWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Elon’s Dec. 31st Surprise “Super-IPO”?There’s a little-known backdoor way to play Elon’s “Super-IPO”… With as little as $50. Paradigm Press | SponsoredFastest Way To Build Wealth From Trump Stock MELT UPDonald Trump is about to ignite the biggest… and fastest… stock market boom in American history. He will be...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiomX Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BiomX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
